USFDA nod to Lupin Brimonidine Tartrate Ophthalmic Solution Ruchika Sharma28 Aug 2024 1:30 PM ISTBrimonidine Tartrate Ophthalmic Solution, 0.1% indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma.
Lupin bags Health Canada nod for biosimilar Pegfilgrastim Ruchika Sharma25 Aug 2024 2:00 PM ISTArmlupeg is available in a form of pre-filled syringe of 6mg/0.6 ml.
Lupin secures USFDA tentative nod for Brimonidine Tartrate Ophthalmic Solution Ruchika Sharma17 Aug 2024 11:33 AM ISTMumbai: Global pharma major Lupin Limited has announced that the Company has received tentative approval from the United States Food and Drug...
Lupin Australia arm incorporates new subsidiary in New Zealand Ruchika Sharma10 Aug 2024 11:00 AM ISTMumbai: Through a recent BSE filing, Lupin has informed that Generic Health Pty Ltd., Australia, a wholly owned subsidiary of the Company, has...
Lupin Announces Positive Results from Global Phase 3 Trial of Lucentis Biosimilar Lalhmangaihkimi8 Aug 2024 10:46 AM ISTLupin recently announced positive results from global phase 3 clinical trials evaluating the immunogenicity, safety, and efficacy of LUBT010—Lupin's...
Lupin incorporates new subsidiary Lupin Lanka in Sri Lanka Ruchika Sharma7 Aug 2024 1:58 PM ISTMumbai: Lupin Ltd. has incorporated Lupin Lanka (Private) Ltd., Sri Lanka, as wholly owned subsidiary of the Company.The Company will make...
Lupin completes Phase 3 trials for Lucentis biosimilar Ruchika Sharma6 Aug 2024 4:30 PM ISTMumbai: Global Pharma major Lupin Limited has announced the successful completion of a global Phase 3 clinical study of LUBT010, its biosimilar...
Justify proposed dose and rationality: CDSCO Panel Tells Lupin on FDC Sacubitril plus Valsartan Dr. Divya Colin5 Aug 2024 6:00 PM ISTNew Delhi: In response to the justification presented by the drug major Lupin on the rationality of the fixed-dose combination (FDC) cardiovascular...
Lupin bags USFDA nod for Prednisolone Acetate Ophthalmic Suspension Ruchika Sharma5 Aug 2024 4:31 PM ISTMumbai: Global pharma major Lupin Limited today announced that it has received approval from the United States Food and Drug Administration (U.S....
Lupin bags tentative USFDA nod for HIV-1 infection drugs Ruchika Sharma31 July 2024 12:30 PM ISTMumbai: Global pharma major Lupin Limited today announced that it has received tentative approval from the United States Food and Drug...
Lupin alliance partner ForDoz gets USFDA nod for Doxorubicin Hydrochloride Liposome Injection Ruchika Sharma23 July 2024 1:20 PM ISTMumbai: Global pharma major Lupin Limited has announced that its alliance partner, ForDoz Pharma Corporation, USA has received approval from the...
Lupin, Huons ink pact for registration, marketing of Cyclosporine Ophthalmic Nanoemulsion in Mexico Ruchika Sharma21 July 2024 12:30 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has signed a license and supply agreement with Huons Co. Ltd for the registration...
